INTRODUCTION
Nowadays, design and development of high performance drug delivery systems (DDSs) have gained great attention by government, scientists and pharmaceutical industry. In fact, the main purpose of an ideal drug delivery systems is to improve the therapeutic efficiency and/or targeted the drugs to desire region while simultaneously reducing the side effects and increase the desired effects of drugs. The naturally derived cytotoxicity agents such as Curcumin (Bar-Sela et al. 2010 ) play potential roles in synergizing our current modality of cancer treatments, including chemotherapy in cancer treatment. Without a good drug delivery carrier, it will cause a poor pharmacokinetic profiles and low specificity of these drugs which may affect their therapeutic efficacy (Bar-Sela et al. 2010) . Thus, choosing an appropriate drug delivery carrier is prior to the success of a DDS. Cancer is the leading cause of death worldwide with an estimated 84 million casualty between 2005 and 2015 (Ucar et al. 2017) . In conjunction to this, breast cancer is the most commonly diagnosed cancer in women around the world (Danhier et al. 2010) . Changes in reproductive factors, environmental exposures, and lifestyle such as dietary uptake and physical activity are the major concerns contributing to breast cancer. Hence, early detection and treatment play a vital role in survival of a patient. However, due to low solubility of most cytoxicity drugs caused by their hydrophobic nature, their efficacies are described to be reduced in the patient's body (Jabbarzadeh et al. 2014) , thus, higher concentration of chemotherapeutic drugs need to be prescribed during treatment. Therefore, it is imperative to find an ideal drug delivery carrier in reducing the conventional dosage of chemotherapeutic drugs without hampering their efficacy in killing those cancerous cells. Among the drug delivery carriers that can be considered for the drug delivery system (DDS), β-CD possesses good potential due to its ability to alter physical, chemical and biological properties of guest molecules by forming an inclusion complex in both solid and solution state, respectively (Memisoglu-Bilensoy et al. 2005) . The main advantages of natural cyclodextrins as a drug carrier include a well-defined chemical structure, allowing space for potential sites for chemical modification, availability of different cavity sizes from α-, β-and γ-cyclodextrin, low toxicity, good pharmacological activity and most importantly, its ability to enhance drug solubility in aqueous solution and affects the chemical characteristics or physicochemical properties of the encapsulated drug. Therefore, β-CD is a suitable candidate to transport the drugs to their target.
Curcumin or Curcuma longa (Figure 1 ), commonly known as diferuloyl methane, is a hydrophobic polyphenol derived from rhizome (turmeric) of the herb which is known to exhibit anti-cancer properties. CUR has been widely studied for its potential to protect cardiovascular disease and has been utilised in neurodegenerative disorders, especially Alzhermer's and Parkinson's disease (Fermeglia et al. 2003) . Besides, CUR also possesses properties such as agent for anti-inflammatory, antioxidant, immunomodulatory, pro-apoptotic and antiangiogenic, as well as chemoprevention agent towards colon, pancreatic, cervical cancers and Barrrets mataplasia (Wilken et al. 2011) . However, CUR has a limited pharmaceutical application due to its low water solubility, poor bioavailability (Yu & Huang 2010) , chemical instability and rapid metabolism (Salem et al. 2015) which may be corresponding for the pharmacokinetics restriction of this molecules (Holder et al. 1978) . Therefore, to further the clinical application of CUR, the search for an efficient and nontoxic carrier for CUR has become more significant. Various methods have been applied to enhance Curcumin delivery, such as incorporating it into phospholipid vesicles (Sou et al. 2008) , liposomes (Li et al. 2005) this transcription factor is a potential target for the treatment of this devastating disease. Curcumin (diferuloylmethane, and nanoparticles (Khan et al. 2016) . Thus, to address the issue related to low solubility of CUR, β-CD is investigated on its suitability as a drug carrier in this study. Although many studies have been carried out with β-CD (Wang et al. 2007; Zhang et al. 2015) and Curcumin (Gafner et al. 2004; Liu et al. 2013) or both (Mangolim et al. 2014) ; to the best of our knowledge, studies of β-CD-CUR inclusion complex focus on its anti-cancer activity in particular towards estrogen receptor (ER) positive human breast cancer cell line (MCF-7 cells) in the scientific literature are scarce and lack reported. Based on reviews, Memisoglu-Bilensoy et al. (2005) loaded β-CDC6 nanospheres into Tamoxifen citrate nanocapsules against MCF-7 cells while Yu and Huang (2010) capsulated the Curcumin into polymer micelles formed by hydrophobically modified starch and tested on human hepatocellular carcinoma cell line HepG2. Both studies demonstrated an efficient anti-proliferative effect of both cytotoxic agents in the presence of those biopolymers. Meanwhile, Jahed et al. (2014) demonstrated the molecular modelling for β-CD-CUR complex, however, assessment on the cytotoxic activity of this complex was not shown in this study. No toxicity study was performed to show the anti-proliferative of the complex. Therefore, we believe this work may enhance the fundamental value towards the supramolecular interaction between β-CD and Curcumin, particularly on their anti-proliferative effect in MCF-7 cells. Nevertheless, complexation with cyclodextrins is a popular combination which may lead to new era for their wide applications in different fields to improve the biological activities of Curcumin in living systems.
MATERIALS AND METHODS

INSTRUMENTATION
The Nuclear Magnetic Resonance 1 H (NMR) spectrum of the samples in dimethyl sulfoxide was recorded using Jeol JNM-GSX 270 at room temperature. The Fourier Transform Infrared (FTIR) spectra were recorded on a Perkin Elmer, System 2000 with samples prepared using Attenuated Total Reflection (ATR) technique. Scanning Electron Microscope Zeiss Supra 50 VP was used to obtain the surface morphology of the host, guest, and host-guest inclusion complex (βCD-CUR) at 5000× magnification. X-Ray Diffraction (XRD) analysis was analysed using Cu Kα irradiation with a Siemens D5000 X-ray diffractometer.
SYNTHESIS OF THE INCLUSION COMPLEX OF β-CD AND CURCUMIN
Inclusion complex between βCD with CUR was prepared using the kneading method. 0.5 g of βCD and 0.16 g of CUR were weighed and kneaded with mortar and pestle in minimum ethanol for 20 min to prepare a 1:1 ratio complex. The mixture was dried in a desiccator for 48 h to constant mass and weighed. The yield percentage for βCD-CUR inclusion complex was 79.94%. The powder was stored at room temperature.
SPECTROSCOPIC STUDIES
Spectroscopic studies were carried out to determine the absorption spectrum, stoichiometry, and formation constant of the β-CD-CUR inclusion complex. A UV-Visible spectrophotometer with 1 cm quartz cells was used for all the following spectroscopic studies. Absorption spectra were determined between 300 and 500 nm (Wang et al. 2007 ).
EFFECT OF pH
Effect of pH for inclusion complex formation was determined by using three different pH buffers. Buffer solutions with pH4, pH7 and pH10 have been used to determine the optimum pH. Subsequently, the optimum pH (pH7) has been used for the absorption spectra and the formation constant. 
STOICHIOMETRY AND FORMATION CONSTANT
The concentration of β-CD was varied in the range 0-0.005 M while the concentration of Curcumin was held constant at 0.00005 M. The data obtained were used to illustrate reciprocal plot for Curcumin-βCD inclusion complex using Benesi-Hildebrand equation (Kuntz et al. 1968 ).
CELL CULTURE AND REAGENTS
Roswell Park Memorial Institute-1640 medium (RPMI-1640 medium) (Gibco BRL, UK), Fetal Bovine Serum (FBS) (Gibco BRL, UK), 10X phosphate buffer saline (Gibco BRL, UK), trypsin 0.25% EDTA 0.003% (Gibco BRL, UK) and penicillin/streptomycin solution 10 mg/mL (Gibco BRL, UK) were used in this study for cell culture and treatment. human breast cancer cell line was maintained in a humidified 37°C incubator with 5% CO 2 . All procedures were conducted in a class 2 Biohazard Cabinet with a proper aseptic technique. Good cell practice guidelines were followed throughout the project.
PREPARATION OF INCLUSION COMPLEX FOR TREATMENT
β-CD-CUR inclusion complex were dissolved in 25 mL of DMSO and shaken. 0.5 mL of the solution was further diluted in 10 mL volumetric flask with RPMI complete growth medium and labelled as stock solution. The stock was filtered with 0.22 μm sterile nylon filter before further dilution with complete growth medium to produce different concentrations (50, 100, 150, 200 and 250 μM).
PREPARATION OF CUR AND Β-CD FOR TREATMENT 1 g of CUR was dissolved in 25 mL DMSO. 0.5 mL of the solution was diluted in 10 mL volumetric flask with RPMI complete growth medium and labelled as stock solution.
The stock was filtered with 0.22 μm sterile nylon filter before further dilution with complete growth medium to produce different concentrations (50, 100, 150, 200 and 250 μM).
MTT CELL PROLIFERATION ASSAY
The MTT Cell Proliferation Assay (Merck Millipore, Germany) was used to determine the anti-proliferative effect of βCD, CUR, βCD-CUR 1:1 complexes on MCF-7 cell line.
TREATMENT CONTROL Treatment controls were set up to determine the percentage of cell viability after treatment with inclusion complex, CUR alone, and β-CD alone. Table 1 shows the positive control, negative control, and background control used in the experiment. MCF-7 cells were harvested from the T75 cm 2 culture flasks using trypsin-EDTA and seeded at 10,000 cells per well in a 96-well plate. The plate was incubated overnight at 37°C with 5% for cells attachment. The culture medium was then replaced by assay medium containing treatment with βCD, CUR and βCD-CUR 1:1 complex. Positive control, negative control, and background control were also included in the assay. All treatments and controls were prepared and loaded in triplicates. The plates were incubated for 24 and 48 h.
PREPARATION OF [3(4,5-DIMETHYLTHIAZOL-2YL)-2,5-DIPHENYLTETRAZOLIUM BROMIDE)] (MTT) SOLUTION
MTT solution was prepared at 5 mg/mL which was dissolved in phosphate buffer saline (PBS) and mixed well. The solution was filtered using 0.22 μm sterile nylon filter and kept at 4°C in the dark.
DETERMINING CELL VIABILITY PERCENTAGE
At each time point, 10 μL of MTT (5 mg/mL) was added to each well and the plate was incubated for 4 h at 37°C with 5% CO 2 . The medium containing the MTT solution was discarded and replaced with 100 μL of DMSO. The optical density of each well was read at 570 nm wavelength using microplate reader. The percentage of cell proliferation was calculated using (1) The FTIR spectra of β-CD show characteristic peaks at 3333 and 2922 cm -1 caused by the O-H and C-H stretching of vibration. Besides that, peaks at 1653, 1276, 1025 and 858 cm -1 indicates the presence of HOH, C-O, C-O-C stretching glucose units and C-O-C of rings of β-CD. In the case of inclusion complex between β-CD and CUR, all the sharp peaks belonging to the β-CD exist and only a few characteristics of CUR peaks are visible. The shifts to all β-CD related peaks were shifted to a higher or lower wavelength such as at 3333 to 3336 cm -1 , 1653 to 1627 cm -1 and 858 to 857 cm -1 . The broader OH stretching band of the inclusion complex in the frequency 3336 cm -1 again corresponds to the multiple OH functional groups of β-CD molecules (Subramaniam et al. 2010; Williams III et al. 1998) . Therefore, these data confirm the presence of CUR and β-CD in the βCD-CUR inclusion complex. Table 2 shows the differences in frequencies between β-CD and their inclusion complex measured in intensity changes δ). The increment was due to the insertion of benzene ring from CUR into the electron rich cavity of β-CD, which increases the density of electron cloud and causes frequency to increase. Whereas, decline in frequency between the inclusion complex and CUR (Table  3) is caused by the changes in the microenvironment that leads to the formation of hydrogen bonding and van der Waals forces in their interaction during the complexation (Jahed et al. 2014) . Thus, the FTIR spectra prove the formation of the βCD-CUR inclusion complex.
X-RAY DIFFRACTION (X-RD) ANALYSIS
X-ray diffraction (XRD) provides further confirmation for the formation of an inclusion complex and it is commonly used to determine the formation of a new compound from FIGURE 2. FTIR spectra of (a) β-CD, (b) CUR, and (c) β-CD-CUR inclusion complex their original molecules (Zhang et al. 2015) . The X-ray diffractogram of CUR and β-CD exhibited sharp, thin and intense peak which showed their characteristic crystalline peaks. This is in accordance with previous reports of CD inclusion complexes (Mangolim et al. 2014; Yallapu et al. 2010) . β-CD has a major peak at 2θ= 9.5°, 11.1° and 12.8° while CUR has a characteristic peak at 2θ= 8.9°,14.8° and 19.6°. In the formation of inclusion complex, the peaks at 2θ= 9.5°, 11.1° and 12.8° of βCD decreased in intensity and sharpness (Figure 3 ). Besides that, characteristic peaks of CUR at 2θ= 8.9°, 14.8° and 19.6° also lost their intensity and broadening. The loss of intensity and increase in peak broadness indicate reduction in degree of crystallinity in the inclusion complex (Mangolim et al. 2014 ). This reduction showed that the complex may be converted from the crystalline into the slightly amorphous form, thereby increasing the rate of CUR dissolution (Rachmawati et al. 2013) . Therefore, the formation of an inclusion compound between β-CD and CUR was confirmed.
H NUCLEAR MAGNETIC RESONANCE (NMR)
SPECTRA ANALYSIS 1 H NMR is a useful tool to confirm the formation of an inclusion complex and to provide useful information on the inclusion mechanism of β-cyclodexrin and the guest molecule (Mohamad et al. 2011 ). The NMR spectrum of the inclusion complex and their parent molecules can be observed in Figure 4 . The chemical shifts between β-CD and the inclusion complex can be seen in Table 4 . The data showed that the most obvious chemical shifts occurred at H-3 and H-5 which are located inside the cavity of the β-CD. The spectrum of β-CD-CUR inclusion complex indicated a shift in H-3 from 3.643 ppm to 3.790 ppm (shifted by +0.147 ppm) and H-5 from 3.606 ppm to 3.679 ppm (shifted by +0.073 ppm). The shifts in H-3 and H-5 were bigger than H-1 (+0.002 ppm), H-2 (-0.040 ppm), H-4 (+0.004 ppm), and H-6 (-0.012 ppm). Thus, the shifts in H-3 and H-5 located inside the cavity of β-CD confirm the formation of an inclusion complex (Jahed et al. 2014) . Other than that, FIGURE 3. X-ray diffractogram of (a) β-CD, (b) CUR, and (c) βCD-CUR inclusion complex 
the slight marginal shift of protons H-2 and H-4 suggests CUR as an interaction only with the internal hole of β-CD and it is not involved in solubility enhancement of CUR (Jahed et al. 2014) . The same phenomenon is observed in H-1 and H-6. Spectrum shifts for CUR to inclusion complex can be observed in Table 3 .3. For the spectrum of a symmetrical compound, two carbons will have similar peaks. For example, in CUR, both Ha and Hg will have a peak at 7.526 ppm. The spectrum belonging to the aromatic ring in CUR shows the most significant shifts at Hi (+0.118 ppm) and Hj (+0.070 ppm), suggesting that the aromatic group of CUR reacted with the inner cavity of β-CD. Moreover, the presence of 1 H signal from both CUR and β-CD in the β-CD-CUR 1 H NMR spectrum indicates the formation of a new inclusion complex.
H COSY spectroscopic technique was studied which is a powerful technique to investigate the intermolecular interaction and confirm the formation of the inclusion complex (Raoov et al. 2013) . Besides that, 2D NMR enables us to determine the interaction between the guest and the host molecules in the complexes and the connectivity between their neighbouring protons in the cavity of the inclusion complex (Gómez-Galván et al. 2016) . The 1 H NMR results showed the presence of a guest molecule inside the cavity of β-CD and can be confirmed by 2D COSY (Mohamad et al. 2011) . The cross-peak in Figure 5 originates from the interaction of protons of β-CD and CUR. The cross peak at 3.679-3.790 ppm which belongs to β-CD (H-3 and H-5) and the aromatic region of CUR at 5.82 ppm Values in bold refer to the highest chemical shift of that particular proton FIGURE 5. The correlation spectra of βCD-CUR inclusion complex in DMSO demonstrates strong intensity. Therefore, we can conclude that the aromatic ring of CUR has entered the cavity of β-CD.
SCANNING ELECTRON MICROSCOPE (SEM) ANALYSIS
SEM studies were conducted to investigate the morphology of β-CD, CUR and βCD-CUR inclusion complex (Figure 6 ). SEM pictures showed that β-CD has a crystalline flake-like structure throughout the sample. CUR on the other hand shows a highly rod-like spherical crystals. However, the β-CD-CUR inclusion complex does not show neither crystalline flakes nor spherical-crystals. Instead, the βCD-CUR inclusion complex exhibits a combination of large and small irregular-shaped clumps. The morphological change from flake-like structure to smaller aggregates is due to CUR encapsulation in the cavities of β-CD. The morphology obtained was in a good agreement with few studies (Rachmawati et al. 2013; Yallapu et al. 2010 ).
THERMOGRAVIMETRIC ANALYSIS (TGA) ANALYSIS
TGA is a frequently used technique for measuring a compound's thermal stability in which TGA will be done on samples to identify the changes in weight percent with respect to temperature change (Sambasevam et al. 2013 )1H Nuclear Magnetic Resonance (1H NMR. In this study, the thermal stability of βCD-CUR was evaluated using TGA and the results were compared with pure β-CD and free Curcumin. Figure 7 shows the weight loss curves for β-CD-CUR and its precursors in the temperature range of 0-800°C. βCD started to decompose at 320°C. Visible changes occurred at 120°C due to the endothermic behaviour which corresponded to the loss of water molecules in βCD cavity. Meanwhile, Curcumin exhibited weight losses at 240°C and 450°C which were due to the degradation of benzyl part. Then the inclusion complex underwent weight losses in three stages and lost 95% of its original weight at 730°C. The first stage is due to the dehydration of water molecules while the second stage is due to decomposition of β-CD and the third stage is probably due to the decomposition of Curcumin. The degradation and weight loss steps of the samples are shown in Table 5 .
SPECTROSCOPIC STUDIES
Effect of pH The effect of pH (pH 4, 7 and 10) has been studied in order to determine the optimum pH of inclusion formation between β-CD and Curcumin. No absorbance was observed for pH10 (as shown in Figure 8 ). pH7 (at 426 nm) was chosen to be the optimum pH rather than pH4 for this inclusion complex due to the ease of experimental preparation. This is a phenomena where at pH7, Curcumin is weak and less stable (Jha et al. 2016) and able to form highly stable inclusion complex with β-CD. Besides that, neutral forms of Curcumin are also predominant at neutral pH which ease the formation of inclusion complex.
9. Based on the result, the increase on the absorbance intensity of the complex was due the formation of the inclusion complex with the β-CD. This can be proven by the fact that increase and shift on the intensities were rationalized act as the indicator of inclusion complex formation (Wang et al. 2007 ). The influence of β-CD concentration on CUR was also studied. As can be seen in Figure 3 .9, the addition of β-CD had caused a noticeable increase in the absorption intensity. This is due to the structure of Curcumin that contains two aromatic ring systems possessing o-methoxy phenolic groups which can be included by β-CD cavity molecule. Upon inclusion in the β-CD cavity, generally the absorbance of the guest molecule will be enhanced due to the shielding of the excited species from no-radiative processes occurring in the bulk solution and also due to the increase in molar absorption coefficient of the inclusion complex (β-CD-CUR) (Mohamad et al. 2011 ). Absorption spectra were used to confirm the formation of inclusion complex. The absorption spectra of β-CD-CUR complex, CUR and β-CD were recorded with accordance to procedure in Section Spectroscopic Studies. The obtained result showed that β-CD had no absorption in the range of 300-500 nm. While CUR had a maximum absorption wavelength at 419 nm, the absorbance of β-CD-CUR was higher than that of CUR at 426 nm as shown in Figure   FIGURE 9 . The absorption spectra of (a) The formation constant is the most important parameter in the study of inclusion behaviour of β-CD. The formation constant for the inclusion complex has been determined by analysing the changes in the intensities of absorption with different concentrations. The formation constant was denoted and the stoichiometric ratio of the β-CD-CUR was determined using modified Benesi-Hildebrand equation (Wang et al. 2007 ). The K value was calculated by dividing the slope with the intercept of straight line obtained from the double reciprocal plot. The apparent formation constant was determined to be 1.093 × 10 -8 mol -1 dm -3 . Hence, we propose that the CUR ideally tends to form inclusion complex in 2:1 ratio due to the presence of two aromatic rings and this can be proved (Wang et al. 2007 ) by the good linear relationship obtained when is plotted against with R 2 = 0.9943 for β-CD-CUR ( Figure  11 ), indicating that the stoichiometric ratio of the complex formed should be 2:1.
increased, where CUR at the highest concentration (250 µM) led to only 30.4% of growth inhibition in MCF-7 cells. Importantly, anti-proliferative effect of CUR was potentiated by the presence of the β-CD. The percentage of cell death was increased from 61.75% to 73.07% in MCF-7 cells treated with β-CD-CUR inclusion complex in which 150 µM concentration of the complex caused the greatest cell inhibition. This shows a trend that percentages of cell death decreased with increasing of β-CD-CUR concentration. At 48 h of incubation period, CUR alone (curve a) inhibited the growth of MCF-7 cells in a dose-dependent manner, in which the maximum anti-proliferative effect was obtained at concentration of 200 µM, with 95.1% of cell death. β-CD-CUR complex at 250 µM concentration inhibited 90.65% growth of MCF-7 cells. Within 48 h incubation period, the percentage of cell death increased proportionally with the increasing concentration of β-CD-CUR inclusion complex. CUR alone needs longer incubation period (48 h) to show its anti-proliferative efficacy in killing MCF-7 cancerous cells, whilst β-CD co-treatment shortens the time exposure for CUR to induce cytotoxic of MCF-7 cells within 24 h of incubation period. These data also demonstrate that β-CD-CUR inclusion complex potently inhibited the MCF-7 cells greater than CUR alone, particularly at 24 h post-treatment at all concentrations tested in this study. The addition of β-CD has potentiated and enhanced the water solubility of CUR probably accounts for the favourable effect (Jahed et al. 2014) , thus speeding up their efficacy to prevent the growth of MCF-7 cells compared to the treatment of CUR alone. This suggests that β-CD delivery is more efficient for curcumin and is therefore a preferred vehicle or a drug carrier. Figure 14 shows the anti-proliferative effects for all treatments, including negative control (untreated cells), positive control (tamoxifen-treated cells), CUR alone, β-CD alone, as well as β-CD-CUR inclusion complex at both 24 h and 48 h, respectively. At 24 h of incubation period, the percentage of cell viability reached 103. % at 50 µM of β-CD, whilst showing a decrease to 29.63% in 150 µM of β-CD-treated cells. Nonetheless, the highest concentration of β-CD alone only caused little cytotoxicity (less than 10% of cell death) at 48 h incubation period. β-CD-CUR inclusion complex potently decreased the proliferation of MCF-7 cells, where only 27% and 9% of viable cells were The possible inclusion mechanism was proposed from the stoichiometric ratio 2:1 as predicted using BenesiHildebrand equation. This is the same finding proposed by Jahed et al. (2014) in which from the result of NMR, it was observed that β-CD interacts with CUR in 2:1 ratio. It also shows that in a stable complex, two aromatic rings of CUR interact with two β-CDs through the hydrogen bonds as shown in Figure 12 .
ANTI-PROLIFERATIVE STUDIES Figure 13 shows the comparison of anti-proliferative effects of β-CD-CUR inclusion complex versus CUR alone at 24 h and 48 h of incubation periods, respectively. At 24 h time point, the percentage of cell death for CUR (curve a) treated cells range from 30.4-64.8 %. The data showed that 100 mM of CUR alone inhibited the highest cell proliferation of MCF-7 cells, which is at 64.8%. However, the percentage of cell death decreased when the concentration of CUR 
CONCLUSION
In this study, we have demonstrated the feasibility of β-CD to encapsulate Curcumin via inclusion complexation by using kneading technique. Our study shows that Curcumin was efficiently encapsulated into the cavity of β-CD and the formation of the inclusion complex was confirmed in the characterization part using FTIR, SEM, TGA, 1 H NMR and XRD. The chemical shifts in each characterization showed pattern or characteristics from their parent molecule in the inclusion complex with slight shifts and differences. Based on the anti-proliferative study, we can conclude that the β-CD is a potential bioorganic drug delivery carrier since it has shown to be effective in inhibiting the growth of MCF-7 cells by not only increasing the solubility and enhancing Curcumin delivery while promoting and improving the anti-proliferative effect of CUR during the complexation rather than CUR alone at 24 h incubation period. Our study brings the idea to support the use of β-CDs as a key tool to improve the pharmaceutical and pharmacological aspects of Curcumin for turning these widely available natural products into effective drugs.
